Effects of varicella vaccination on herpes zoster incidence

Clinical Microbiology and Infection

Volumn 10, Issue 11, 2004, Pages 954-960

  Wagenpfeil, Stefan ^a   Neiss, A ^a   Wutzler, P ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chickenpox; Population models; Review; Shingles; Vaccination; Varicella zoster virus

Indexed keywords

VARICELLA ZOSTER VACCINE;

AWARENESS; CLINICAL OBSERVATION; CLINICAL STUDY; HEALTH PROGRAM; HEALTH SURVEY; HERPES ZOSTER; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION RISK; MATHEMATICAL MODEL; POPULATION MODEL; PREDICTION; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VIRAL CONTAMINATION; VIRUS REACTIVATION; WILD TYPE;

HERPES; HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 9444233906     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.01020.x     Document Type: Review

References (26)

1. Centers for Disease Control. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR-11): 1-36.
2. Klose T, Banz K, Wagenpfeil S et al. Varicella vaccination in Germany: an analysis with focus on the impact on age-shifts and the elimination of the disease. Eur J Public Health 2002; 12(suppl): 68.
3. Banz K, Wagenpfeil S, Neiss A et al. The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine 2003; 21: 1256-1267.
4. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunization in Greece: retrospective study and systematic review. BMJ 1999; 319: 1462-1467.
5. Gershon A. Varicella vaccination in the USA: an update. In: Handout for the 7th Meeting of the European Working Group on Varicella Warsaw: VZV Research Foundation, 2002; 1-7.
6. Garnett G, Grenfell B. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 1992; 108: 513-528.
7. Thomas S, Hall A. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4: 26-33.
8. Coplan P, Black S, Rojas C et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 2001; 20: 641-645.
9. Lin F, Hadler J. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 2000; 181: 1897-1905.
10. Seward J, Watson B, Peterson C et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287: 606-611.
11. Ray P, Zhang L, Lewis E, Shinefield H, Black S. A comparison of pre and post varicella vaccine licensure hospitalization rates for varicella and herpes zoster. In: Weddle A, ed. Proceedings of the 3rd International Pediatric Infectious Disease Conference, Monterey, CA. Alexandria, VA: Paediatric Infectious Diseases Society, 2001; 136.
12. Goldman G. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 2003; 21: 4243-4245.
13. Goldman G. Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance. Vaccine 2003; 21: 4238-4242.
14. Halloran M, Watelet L, Struchiner C. Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Math Biosci 1994; 121: 193-225.
15. Brisson M, Edmunds W. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making 2003; 23 76-82.
16. Brisson M, Gay N, Edmunds W, Andrews N. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507.
17. Thomas S, Wheeler J, Hall A. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360: 678-682.
18. Brisson M, Edmunds W, Gay N, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000; 125: 651-669.
19. Edmunds W, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 2002; 44: 211-219.
20. Centers for Disease Control. Varicella. In: Epidemiology and prevention of vaccine-preventable diseases. The pink book course textbook, 8th edn. Atlanta, GA: Centers for Disease Control, 2004; 159-175.
21. Seward J, Jumaan A, Galil K, Wharton M. Varicella vaccine and shingles: in reply. JAMA 2002; 287: 2211-2212.
22. Solomon B, Kaporis A, Glass A, Simon S, Baldwin H. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J Am Acad Dermatol 1998; 38: 763-765.
23. Terada K, Hiraga A, Kawano S, Kataoka N. Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster-virus in patients with herpes zoster. Kansen Zasshi 1995; 69: 908-912.
24. LaRussa P, Steinberg S, Gershon A. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996; 174(suppl 3): S320-S323.
25. Gershon A, LaRussa P, Steinberg S, Mervish N, Lo S, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis 1996; 173: 450-453.
26. Levin M, Smith J, Kaufhold R et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003; 188: 1336-1344.